What is Donepezil-memantine?

Category: Prescription Drugs

Most popular types: Namzaric

false

This is a combination medication with a cholinesterase inhibitor and a NMDA receptor antagonist, respectively, both of which are used for treatment of Alzheimer's disease.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 0
Mild 0
None 1

Commonly reported side effects and conditions associated with Donepezil-memantine

Side effect Patients

Why patients stopped taking Donepezil-memantine

Multiple reasons could be selected

Reason Patients
Other 1
See 1 patient who's stopped taking Donepezil-memantine

Duration

Stopped taking Donepezil-memantine

Duration Patients
Less than 1 month 1
Adherence
Adherence Evaluations
Always 1
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 1

What people switch to and from

Patients started taking Donepezil-memantine after stopping:

Treatment Patients
Amantadine (Symmetrel) 1

Patients stopped taking Donepezil-memantine and switched to:

Treatment Patients
Donepezil (Aricept) 1
Last updated:
There are no evaluations for Donepezil-memantine.